Biological medicine is listed the strategic new industry Rob twelve five commanding points in Guangdong

Biological medicine is listed the strategic new industry Rob twelve five commanding points in Guangdong
Though the national biological medicine industry " Twelve five " Planning has not opened veils formally yet, but Guangdong has already begun to dispose in full preparation, seize the commanding point of future. Recently, the reporter is from " advances industry's independent innovations seminar of biological medicine " On know have biological medicine listed Guangdong in and develop already strategically one of industry, the goal is to make the transition to the strong province of pharmacy from the large province of pharmacy.
Try to be the first to list biological medicine in the strategic new industry in dynamic Guangdong
In August of this year, there is news that claims, " twelve five " Biological medicine revitalize plan, issue in will it be the last ten days August, biological medicine " twelve 5 plan " Having confirmed the focal point of development of biological medicine, including the genomic medicine, protein medicine, resisting and cloning the medicine, treatment vaccine, small molecule chemical medicine etc. only.
Meanwhile, have, participate in, make great new medicine formulate national the intersection of science and technology and great the intersection of project and " the twelve 5 " The expert who implements the plan reveals, the country will take more than 12 billion yuan out and support great new medicine to formulate, each new medicine may obtain 5 million - project fund of 10 million yuan on average.
"In the internationalized respect of new medicine, we have already fallen behind India now. " Vice President of College of Pharmacy of Zhongshan University, project centre director Professor Wu ChuanBin of innovative medicine preparation of university of Guangdong Province say with deep feeling, already many innovative preparations have squeezed into the American-European market now in India, and reduce production and export of low profit raw materials medicine gradually. "This may have something to do with policy support of India vs. pharmacy trade and development tactics of the trade. "
Wu ChuanBin says, in recent years though the low end raw materials medicine and total amount of export of the intermediate of our country are still improved to some extent, and may exceed India, develop low end raw materials medicine and export mode of the intermediate of the tall polluting, low profit, green economic development tactics and developing direction of the pharmacy trade of the developed country of environmental protection advocated with our country at present are not identical. So, recommend the research and development of advanced preparation of high profit, low pollution and already accord with our country's modern economic developing direction, accord with the modern pharmacy industry's development trend again.
Obviously, China's biological medicine demands autonomous innovation urgently, and the space on this market is very enormous. According to external experience, the patent of innovative medicine was generally 20 in period, it doesn't exceed 10 years to monopolize the market, but these will spend 10, invest new medicine at 1 billion dollars easily, perhaps the sales amount in one year can reach 1 billion dollars. The expert points out, good innovative medicine even so long as recalls costs in one or two years, it is qualified " High risk, high investment, high repayment " .
Therefore, though the biological medicine industry of the national aspect revitalizes and plans not to issue yet, but all parts have already begun to foster the arrangement of the biological medicine industry in full preparation, for instance governments such as Jiangsu, Shanghai, Beijing, Sichuan and other places all bring biological medicine into the on-going new industry to revitalize in the plan, and Guangdong is unwilling to be lag behind.
On September 2 " Advance industry's independent innovations seminar of biological medicine " Go, the food medicines chief of supervision bureau Chen YuanSheng in Guangdong Province reveals, in the project of Guangdong Province modern industry 500 tops which the provincial government prints and distributes of this year, the strategic new industry project has 103 items, 16 items among them are biological medicine projects. Biological medicine is listed in 11 pieces of strategic new industry of developing especially too, foster actively.

|